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Abstract
Background: The application of sunscreen is a critical component of a sun-safe strategy, however the possibility
of unexpected, adverse outcomes resulting from long-term use of sunscreens containing nanoparticles of titanium
dioxide (TiO2) and zinc oxide (ZnO) has not yet been examined. Here, immune-competent hairless mice were
exposed over a 36-week period to weekly topical applications of sunscreens containing nanoparticles of ZnO or
TiO2, or no metal oxide nanoparticles, with or without subsequent exposure to ultraviolet radiation (UVR). Control
groups received no sunscreen applications, with or without UVR.
Results: Mice exposed to UVR in the absence of sunscreen developed statistically significant incidences of
histologically-diagnosed malignant and benign skin neoplasms, whereas no statistically significant adverse
biological outcomes were found in mice treated with the sunscreens containing ZnO or TiO2 nanoparticles.
Elevated levels of Ti were detected in the livers of mice treated with sunscreen containing TiO2 nanoparticles
compared to untreated control, but total Zn concentrations did not significantly alter in any major organs except
for the skin of mice treated with ZnO sunscreen. Exposure to UVR did not have a significant impact on examined
tissue concentrations of Zn or Ti. Few to no transcriptional changes were found in ZnO or TiO2-treated groups,
but mice treated with the sunscreen containing only organic filters showed substantial gene disregulation.
Conclusions: Taken together with previous work, this long-term study provided no basis to avoid the use of
sunscreens containing metal oxide nanoparticles.
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Background
Whilst some exposure of naked skin to sunlight is benefi-
cial for human health [1], the demonstrated consequences
of prolonged exposure of unprotected skin to ultraviolet
radiation (UVR) include inflammation, premature photo-
ageing, DNA damage, photocarcinogenesis, and immune
suppression [2, 3]. The regular application of sunscreen
has been shown to decrease the risk of developing squa-
mous cell carcinomas in humans, as well as correlated
with decreased risk of developing melanomas and basal
cell carcinomas [4]. Therefore, when long periods out-
doors are anticipated, the regular application of sun-
screens is encouraged (e.g. [5–7]).
The active ingredients in topically-applied sunscreens
generally fall into two categories: organic or inorganic.
Organic UVR filters typically contain aromatic ring
structures that absorb radiation in the UV waveband
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and may bear functional groups that act as electron do-
nors and receptors following exposure to UVR. In con-
trast, inorganic metal oxide particles, typically titanium
dioxide (TiO2) or zinc oxide (ZnO), form a physical bar-
rier between the skin and UVR. Both organic and inor-
ganic filters have been used in sunscreens for decades, but
the latter were typically confined to small areas of high ex-
posure, such as the nose, due to their opaque appearance
on skin resulting from the use of pigment-sized parti-
cles. Nano-sized (defined here as having at least one
dimension <100 nm [8]) particles of TiO2 and ZnO have
been used in sunscreens since the 1980s, becoming more
widespread from the 1990s [9]. Their development has re-
sulted in modern formulations that are highly effective
UVR filters yet are also transparent and light-textured on
the skin [9], superseding the thick, white creams of yester-
year. Whilst ZnO is protective against both UVB and
UVA, TiO2 is typically partnered with organic filters to
achieve broad spectrum protection.
The European Union (EU) Commission’s Working
Group on Cosmetics recently concluded, on the basis of
comprehensive safety dossiers, that the inclusion of nano-
sized ZnO [10] and TiO2 [11] up to 25 % in dermally-
applied cosmetic products posed no risk for adverse health
effects in humans. Similarly, Australia’s Therapeutic
Goods Administration (TGA) has twice concluded that
there is no evidence to show that TiO2 and ZnO nanopar-
ticles are not safe for human use in sunscreens [12, 13],
and a comprehensive review commissioned by the Danish
Environmental Protection concluded that topically applied
nanoparticles are unlikely to undergo dermal penetration
under most conditions, although some conditions may en-
hance penetration to a very small degree [14]. The major-
ity of scientific reviews in peer-reviewed journals have
reached similar conclusions. Thus, we can suggest that a
scientific consensus is being reached that nanoparticles in
sunscreens are safe for use in humans. Nevertheless, some
uncertainty remains with respect to possible biological im-
pacts arising from long-term use of these sunscreens [11].
This, combined with the novelty of nanotechnology, has
led to speculation within some sections of the community
that nanoparticle-containing sunscreens may be unsafe in
the long-term (e.g. [15]) despite clear evidence that the
avoidance of sunscreens altogether can leave the skin ex-
posed to the known damaging effects of UVR. This study,
which specifically compares the biological outcomes of
long-term intermittent UVR exposure, with or without
the protection of topically-applied sunscreens containing
either metal oxide nanoparticles and/or organic filters, ad-
dresses some of these concerns.
An immune-competent hairless mouse model was
chosen to provide a highly sensitive model of skin pene-
tration relative to humans [16], whilst retaining a com-
parable response profile to UVR [17–22]. Three
types of commercially-available sunscreens were applied to
the backs of mice over the course of 36 wks, with and with-
out exposure to UVR (Series 1). One sunscreen contained
only ZnO nanoparticles as the active ingredient, the second
contained a mixture of TiO2 nanoparticles and organic ac-
tive ingredients [octylmethoxycinnamate (OCM); butyl
methoxydibenzoylmethane (B-MDM)], and the third con-
tained only organic active ingredients (OCM, 99 mg/mL;
B-MDM, 19.8 mg/mL; (4-methylbenzylidene camphor
(4-MBC), 39.6 mg/mL; octocrylene, 9.9 mg/mL). A
follow-up study (Series 2) assessed only control groups (no
sunscreen ± UVR) compared to ZnO treatment groups
(± UVR). The mice wore Elizabethan collars during treat-
ment periods to limit ingestion of sunscreen by licking.
Results
Treatment groups in Series 1 and 2 are summarised in
Table 1.
Characterisation of nanoparticles extracted from
sunscreens
The morphologies and size distributions of nanoparticles
extracted from the ZnO and TiO2 sunscreens are shown
in Fig. 1. Both ZnO and TiO2 particles were typically
spheroidal in appearance, and had average diameters of
18.2 ± 0.4 nm (n = 233), and 21.5 ± 0.6 nm (n = 257), re-
spectively. A two-tailed t-test showed that the ZnO parti-
cles were significantly smaller than the TiO2 (p < 0.0001).
However, as the shapes and sizes of the ZnO and TiO2
nanoparticles were comparable, any difference in their ef-
fects is likely to be due to their chemical composition and
related properties.
Macroscopic and histopathological outcomes in mice
On completion of both the Series 1 and Series 2 experi-
ments, mice receiving treatments of UVR with no
Table 1 Treatment groups in Series 1 and Series 2
Group ID Treatment
Series 1 Control-UVR No sunscreen, no UVR
Control + UVR No sunscreen + 29 kJ/m2 UVR
ZnO-UVR ZnO sunscreen, no UVR
ZnO + UVR ZnO sunscreen + 29 kJ/m2 UVR
TiO2-UVR TiO2 sunscreen, no UVR
TiO2 + UVR TiO2 sunscreen + 29 kJ/m
2 UVR
Organic-UVR Organic sunscreen, no UVR
Organic + UVR Organic sunscreen + 29 kJ/m2 UVR
Series 2 2-Control-UVR No sunscreen, no UVR
2-Control + UVR No sunscreen + 27 kJ/m2 UVR
2-ZnO-UVR ZnO sunscreen, no UVR
2-ZnO + UVR ZnO sunscreen + 27 kJ/m2 UVR
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sunscreen had developed significantly thicker skin in the
dorsal region (Control + UVR): 2.5 ± 0.4 mm, n = 5;
2-Control + UVR: 2.1 ± 0.2 mm, n = 8) compared to
untreated mice (Control-UVR: 0.75 ± 0.02 mm, n = 10; 2-
Control-UVR: 0.83 ± 0.01 mm, n = 10) (p < 0.0001). Other
treatment groups did not show a similar skin thickening,
with means ranging from 0.74 ± 0.01 (ZnO-UVR, n = 10)
to 0.77 ± 0.04 (TiO2 + UVR, n = 10) in Series 1, and
0.82 ± 0.02 (2-ZnO-UVR, n = 10) to 0.86 ± 0.02 (2-
ZnO + UVR, n = 9) in Series 2. Non-malignant skin
neoplasms (sessile-based papillomas, macules, and pe-
dunculated papillomas) were identified macroscopic-
ally for Series 1 on the dorsa of 4 of the 10 mice from
Control + UVR, but were not assessed in Series 2. Mice
showed no statistically significant difference in average
body or organ weights, and no other macroscopic out-
comes were observed.
Of the total of 120 mice used across Series 1 and 2, 105
maintained good health throughout the experimental
periods and reached the pre-determined experimental
endpoints of 36 weeks for both Series. Of these 105 mice,
86 were classified as normal and 19 were diagnosed with
sub-clinical problems in a post-mortem analysis per-
formed by a veterinary histopathologist employed on a
commercial basis. Details of histopathological findings are
given in Table 2. A total of 15 of the 120 mice used across
Series 1 and Series 2 suffered unscheduled adverse events
and were either euthanized for ethical reasons (12 mice)
or were found dead in the cage (3 mice), and thus did not
reach the pre-determined experimental endpoints.
Apart from the expected UVR-induced dermal neo-
plasms observed for mice in the UV-irradiated groups re-
ceiving no sunscreen (Control + UVR, 2-Control + UVR)
(Fig. 2), post-mortem examinations found no statistically-
significant common cause to any of the histologically-
diagnosed pathologies in mice that reached the
experimental endpoint or suffered unscheduled adverse
events across Series 1 and Series 2.
Levels of tissue Zn
The levels of Zn were measured by ICP-MS in the skin,
brain, liver, spleen, kidney, and lung tissues from control
and ZnO-treated groups in Series 1, and are shown in
Table 3. Mice receiving weekly topical applications of sun-
screen containing ZnO nanoparticles showed elevated
concentrations of Zn in the skin (ZnO-UVR: 82 ± 9 μg/g;
ZnO +UVR: 73 ± 10 μg/g) compared to mice receiving no
sunscreen (Control-UVR: 14.5 ± 0.7 μg/g; Control + UVR:
13 ± 2 μg/g). No difference was found between ZnO-UVR
and ZnO +UVR. Elevated concentrations of Zn were not
found in any of the other tissues examined.
Levels of Liver Ti
Total Ti concentrations were measured by ICP-MS in liver
tissues from Control-UVR, TiO2-UVR, and TiO2 +UVR,
and are shown in Fig. 3. Mice exposed to topical applica-
tions of sunscreen containing TiO2 nanoparticles once
per week over 36 weeks (TiO2-UVR and TiO2 + UVR)
showed significantly elevated levels of Ti in liver tissue
(0.31 ± 0.02 μg/g and 0.33 ± 0.02 μg/g, respectively) com-
pared to untreated mice (Control-UVR: 0.19 ± 0.2 μg/g).
No difference was found between TiO2-UVR and
TiO2 + UVR. The source of background Ti (i.e. in un-
treated mice) is likely to have been food, which was
analysed and found to contain 0.3 mg/kg Ti.
Whole-genome gene-expression profiling in livers
No statistically-significant differentially-expressed tran-
scripts were identified in ZnO-UVR, ZnO +UVR, or
TiO2-UVR compared to Control-UVR, and so these
groups were excluded from further transcript analysis. In
contrast, statistically significant alterations in transcript
levels were identified in mice from Control + UVR, TiO2
+ UVR, Organic-UVR, and Organic + UVR for a subset
of genes compared to untreated mice, and thus further
analyses were performed for these groups using IPA
software to identify perturbed transcriptional pathways.
Fig. 1 a TEM images of ZnO and TiO2 particles extracted from their respective sunscreens. Scale bar = 100 nm; b Histogram showing the distribution
of particle diameters. 233 and 257 measurements were made for ZnO and TiO2 particles, respectively
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Table 2 Histological findings for all treatment groups from Series 1 and Series 2














































Series 1 Control-UVR None 0 10 10 0 0 0 0 0 0 10
Control + UVR None 29 10 6 4 4 (1 X CFS;
1 X CFS + SCC;
1 X LL; 1 X SCP)
0 0 1 (1 X SCP) 4a 1
ZnO-UVR ZnO 0 10 10 0 0 0 0 0 1 (1 X PA) 9
ZnO + UVR ZnO 29 10 5 5 1 (1 X LL) 2 (1 X N; 1 X HC) 2 1 (1 X CFS) 0 4
TiO2-UVR TiO2 0 10 9 1 0 1 (1 X P) 0 0 0 9
TiO2 + UVR TiO2 29 10 10 0 0 0 0 2 (2 X BAC) 1 (1 X PA) 7
Organic-UVR Organic 0 10 9 1 1 (1 X LL) 0 0 0 0 9
Organic + UVR Organic 29 10 9 1 0 0 1 1 (1 X LL) 0 8
Series 2 2-Control-UVR None 0 10 10 0 0 0 0 0 0 10
2-Control + UVR None 27 10 9 1 1 (1 X LL) 0 0 7 (1 X BAC; 4 X SCC;
1 X LL; 1 X CFS & SCP)
0 2
2-ZnO-UVR ZnO 0 10 9 1 1 (1 X LL) 0 0 1 (1 X OS) 0 8
2-ZnO + UVR ZnO 27 10 9 1 0 1 (1 X E) 0 0 0 9
The predetermined endpoint for both groups was 36 weeks
CODE: AE adverse event, BAC bronchioalveolar carcinoma, CFS cutaneous fibrosarcoma, E endometritis, HC haemolytic crisis, LL lymphocytic lymphoma, N nephropathy, OS osteosarcoma, P peritonitis, PA pulmonary
adenoma, SCC squamous cell carcinoma, SCP squamous cell papilloma















As depicted in Fig. 4, mice receiving the combination
of organic sunscreen and UVR (Organic + UVR) showed
by far the greatest disruption to the transcriptome, with
a total of 5933 genes differentially regulated compared
to untreated mice (Control-UVR). In the absence of
either the organic sunscreen (Control + UVR) or the UVR
(Organic-UVR), mice exhibited far less disturbance to
their transcriptomic activity, with totals of 1029 and 720
genes differentially regulated, respectively. In contrast,
mice treated with both the TiO2 sunscreen and UVR
(TiO2 + UVR) showed only very low levels of differential
regulation compared to untreated mice (Control-UVR)
(14 genes).
Information on all differentially-expressed genes from
all treatment groups relative to no treatment is available
under GEO accession number GSE84818. The top 5
Canonical Transcriptional Pathways showing the most
substantial disruption in treatment groups are listed in
Table 4, although it should be noted that the identification
of canonical pathways by IPA and similar programs that are
based on gene and pathway citations in research literature
can be subject to bias towards areas of greater research ef-
fort and literature abundance. Three of the five most sub-
stantially perturbed by UVR treatment in the absence of
sunscreen (Control + UVR) were associated with the re-
sponse to DNA damage (Role of BRCA1 in DNA Damage
Response; ATM signalling; DNA Double-Strand Break
Repair by Non-Homologous End Joining), and a fourth
(NF-kB Signaling) was a rapid response pathway to cellular
damage. The fifth, Cholecystokinin/Gastrin-Mediated
Signalling, is a molecular messaging pathway implicated
in a variety of biological functions that, amongst others,
include cell proliferation and neoplastic transformation. In
contrast, three of the Top 5 Canonical Pathways that were
disrupted in mice receiving topical applications of TiO2
sunscreen prior to UVR (TiO2 + UVR) were associated
with metabolic functions (Tetrapyrrole Biosynthesis II;
Heme Biosynthesis II; Mevalonate Pathway I). The
Circadian Rhythm Signalling and Breast Cancer Regulation
by Stathmin1 Canonical Pathways also showed altered
regulation in this group. Mice receiving topical treatments
Fig. 2 Images of representative histological skin sections from mice
from Series 1 and 2 receiving: a no treatment; b weekly exposure to
UVR with no sunscreen; c weekly exposure to UVR with pre-applications
of sunscreen containing nanoparticles of ZnO as the only UV active
ingredient; d weekly exposure to UVR with pre-application of sunscreen
containing nanoparticles of TiO2 and organic UV active ingredients;
e weekly exposure to UVR with pre-application of sunscreen containing
only organic UV active ingredients. Images on the left were taken from
mice in Series 1, and on the right in Series 2. The only treatment-specific
effects were in the mice receiving UVR treatments with no sunscreen
(Control + UVR), here represented by a squamous cell papilloma (SCP)
in Series 1 (encompassed by a black bracket), and in Series 2 (i) a
cutaneous fibrosarcoma (CFS) (black arrow indicates mitotic figure in
fibrosarcoma) and (ii) squamous cell carcinoma (SCC) (black arrow
indicates “keratin pearl” in SCC). The skin from all other treatment groups
showed unremarkable epidermis and dermis
Table 3 Mean concentrations of Zn in tissues (wet mass) from untreated mice, and treated mice receiving UVR only, or ZnO
sunscreen (± UVR) in Series 1
Group ID Sunscreen UVR (kJ/m2) μg/kg Mean μg/g ± SEM
Skin Brain Liver Spleen Kidney Lung
Series 1 Control-UVR None None Zn 14.5 ± 0.7 12.2 ± 0.8 19 ± 1 17.4 ± 0.5 14.8 ± 0.7 16.9 ± 0.5
Control + UVR None 29 Zn 13 ± 2 15 ± 3 20 ± 1 17.6 ± 0.6 15.7 ± 0.8 16.6 ± 0.6
ZnO-UVR ZnO None Zn 82 ± 9a 12.1 ± 0.6 21 ± 1 18.2 ± 0.1 16.6 ± 0.6 16.1 ± 0.4
ZnO + UVR ZnO 29 Zn 73 ± 10a 13 ± 1 21 ± 1 17.3 ± 0.5 17.3 ± 0.7 16.4 ± 0.4
The practical quantification limit of Zn was 0.4 μg/kg; n = 5 for all tissues in all groups except for Control + UVR Skin, for which n = 4
SEM Standard Error of the Mean
aSignificantly different from untreated mice (Control-UVR)
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of the organic sunscreen with (Organic + UVR) or without
(Organic-UVR) subsequent UVR exposure shared two of
their Top 5 Canonical Pathways, with the Estrogen
Receptor Signalling and Remodeling of Epithelial Adherens
Junctions Pathways showing substantially altered regula-
tion in both. However, in the absence of UVR (Organic-
UVR), two of the remaining three Top 5 Pathways were
associated with metabolic functions (All-trans-decaprenyl
Diphosphate Biosynthesis; Phosphatidylethanolamine
Biosynthesis II), whereas in the presence of UVR
(Organic + UVR) the remaining three pathways in the Top
5 were indicative of altered protein regulation (Protein
Ubiquitination Pathway; tRNA Charging; EIF2 Signaling).
It should be noted, however, that whilst the different
treatment regimes resulted in variation amongst the Top 5
Canonical Pathways, these pathways were often also dis-
rupted by the other treatments, but not as strongly.
Discussion
This study sought to address the question of whether
long-term use of sunscreens containing metal oxide
nanoparticles could lead to adverse health effects com-
pared to a sunscreen containing only organic UVR fil-
ters, or no sunscreen at all. As sunscreen is typically
used to protect the skin from the sun, it was important
to include UVR as a variable, particularly in light of the
photocatalytic potential of ZnO and TiO2 nanoparticles
and the potential for temporary disruption of the skin bar-
rier function following UVR exposure. Two 36-week ex-
periments were conducted in which immune-competent
hairless mice received weekly topical applications of
commercially-available sunscreens, or no sunscreen,
followed by UVR exposure or no UVR.
The major findings of the study are aligned with general
sun-safe messages that advocate the application of sun-
screen to skin when exposed to UVR in the absence of
protective clothing; i.e. sunscreen protects the skin against
UVR-mediated damage. These results also counter recent
speculations within some sections of the community that
sunscreens containing metal oxide nanoparticles may be
more dangerous than no sunscreen at all [23]. We found
that the topical use of sunscreens protected hairless mice
from histologically-diagnosed UVR-induced malignant
and non-malignant skin neoplasms, and dermal inflam-
mation, irrespective of whether their active ingredients
included metal oxide nanoparticles and/or organic filters.
This is consistent with previously published work showing
that sunscreen use can decrease incidences of solar actinic
keratoses [24], melanoma [25], and squamous and basal
cell carcinomas [26] in humans. We found no other
statistically-significant histological outcomes with respect
to the long-term use of ZnO or TiO2 nanoparticles or or-
ganic filters in sunscreens. These results thus support the
recent position of the Scientific Committee on Consumer
Safety that TiO2 and ZnO nanoparticles in sunscreens are
not considered to be harmful to humans after topical ap-
plication [11, 27].
Fig. 4 a VENN diagram showing the number of unique or shared
transcripts within and between mice exposed to UVR, with (TiO2 + UVR,
Organic + UVR) or without (Control + UVR) prior application of sunscreen.
Numbers indicate differentially-expressed transcripts that were either
unique to one treatment (unshared VENN), or differentially-expressed
in more than one treatment (intersecting VENN); b VENN diagram
showing the number of unique or shared transcripts within and
between mice receiving topical applications of the organic sunscreen,
with (Organic + UVR) or without (Organic-UVR) subsequent
UVR exposure
Fig. 3 Mean concentrations of Ti in livers (dry mass) of untreated mice,
and mice receiving TiO2 sunscreen (± UVR) in Series 1. *Significantly
different from untreated mice (Control-UVR) (p < 0.001)
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Dermal penetration by nanoparticles in sunscreen was
not the focus of this study and was not controlled as we
cannot exclude the possibility of chronic low-level inges-
tion of residual sunscreen after washing each week.
Bearing this in mind, the presence of UVR here did not
significantly alter the concentrations of Zn in brain,
heart, liver, kidney, or spleen tissue, or Ti in liver, com-
pared to the concentrations in mice receiving sunscreen
applications without UVR. This suggests that, with long-
term sunscreen use, UVR does not substantially alter the
dermal penetrability of metal oxide nanoparticles when
sunscreens are applied prior to UVR exposure.
Internal tissue concentrations of Zn were not elevated
in mice treated with the ZnO sunscreen, whereas the
concentration of Ti was slightly elevated in the livers of
mice treated with the TiO2 sunscreen. Whilst it is not
possible to exclude dermal penetration, a far more likely
route of entry was via ingestion of either particles from
licking each other during treatment periods (although
this was not observed), or from licking residual particles
left in hair follicles and skin furrows after washing dur-
ing routine grooming (i.e. after the Elizabethan collars
had been removed each week). The difference between
the absence of Zn accumulation and observed low-level
accumulation of Ti in the livers may reflect the differing
solubilities of the more soluble ZnO compared to the
much less soluble TiO2 nanoparticles, highlighting that
the fate of nanoparticles following internalisation into
organs and cells may differ according to their physical
and chemical characteristics. Alternatively, if the same
(low) levels of Zn and TiO2 were internalised dermally
or via ingestion, it would be easier to detect a measure-
able change in concentration for Ti than Zn, simply due
to the very different background or endogenous concen-
trations which are much higher for Zn, where Zn is an
endogenous metal cofactor with normal homestatic
mechanisms, whereas Ti is a contaminant needing hep-
atic decontamination and egestion. Indeed, this was the
reason for using the stable isotope method in previous
work where one of the aims was to assess dermal pene-
tration of Zn from ZnO sunscreen in humans and mice
[28]. Interestingly, however, Cho et al. [29] reported
higher absorption, organ distribution, and urine excre-
tion of Zn from orally-administered ZnO nanoparticles
in mice, compared to TiO2, which was largely expelled
via the faeces. This difference may reflect the differing
route of administration and doses used. We did not as-
sess tissue concentrations of the organic filters here, but
work elsewhere has suggested that they may undergo
time- and dose-dependent systemic absorption in
humans [30, 31].
As might be anticipated, the transcriptional pathways
most substantially disrupted by treatment with UVR
without protection from sunscreen were associated with
responses to inflammation and DNA damage. In con-
trast, for the treatments with the organic sunscreen with
or without UVR, the most significantly altered pathways
were associated with hormone signalling, cell signalling,
and protein synthesis. UVR does not appear to be a fac-
tor in increasing absorption of organic UVR filters [31],
and therefore the dramatic increase in transcriptional
disruption in mice treated with the organic sunscreen
with UVR compared to without UVR is interesting. This
could be due to either compounds produced in organic
sunscreen during irradiation, or production of com-
pounds by the skin when in contact with organic sun-
screen during irradiation. To distinguish between these
possibilities, future work could include a group where
the organic sunscreen is treated with UVR before being
placed on the skin of mice which are not subsequently
exposed to UVR.
Interestingly, long-term exposure to the TiO2 sun-
screen induced very few changes to the transcriptional
profile, despite having two organic UV filters in common
with the organic-only sunscreen. This may indicate that
the transcriptional changes observed in the organic
sunscreen-treated mice may have been largely mediated
by the two additional filters that were present only in
Table 4 Top 5 canonical transcriptional pathways perturbed in treated, relative to untreated, mice from Series 1
Group ID Sunscreen UVR (kJ/m2) Top 5 canonical pathways
Control + UVR None 29 Role of BRCA1 in DNA Damage Response; Cholecystokinin/Gastrin-Mediated Signalling; ATM Signalling;
NF-kB Signalling; DNA Double-Strand Break Repair by Non-Homologous End Joining
ZnO-UVR ZnO 0 No statistically significant differentially expressed genes identified
ZnO + UVR ZnO 29 No statistically significant differentially expressed genes identified
TiO2-UVR TiO2 0 No statistically significant differentially expressed genes identified
TiO2 + UVR TiO2 29 Circadian Rhythm Signalling; Tetrapyrrole Biosynthesis II; Heme Biosynthesis II; Breast Cancer Regulation
by Stathmin1; Mevalonate Pathway I
Organic-UVR Organic 0 Estrogen Receptor Signalling; UVA-induced MAPK Signalling; All-trans-decaprenyl Diphosphate Biosynthesis;
Remodelling of Epithelial Adherens Junctions; Phosphatidylethanolamine Biosynthesis II
Organic + UVR Organic 29 Protein Ubiquitination Pathway; tRNA Charging; Estrogen Receptor Signalling; Remodelling of Epithelial
Adherens Junctions; EIF2 Signalling
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the organic sunscreen. Of those, octocrylene is not
currently known to have endocrine-disrupting activity,
but 4-MBC has been demonstrated to induce dose-
dependent estrogenic activity in vivo in rodent models
when applied orally or topically [32, 33]. However, it is
important to note that in a human study where young
adult males or post-menopausal women were treated
with 4-MBC daily over 2 weeks, no endocrine disruption
was observed, and the European Scientific Committee
on Consumer Products has also concluded that 4-MBC
poses no risk to humans [34, 35]. Therefore, whilst some
transcriptional changes were observed in mice in this
study, this does not necessarily translate to adverse ef-
fects in humans. No statistically significant changes in
transcript levels were identified in mice treated with the
ZnO sunscreen with or without UVR, or the TiO2 sun-
screen with no UVR after 36 weeks of exposure.
The anatase form of TiO2, which is much more photo-
catalytic than the rutile phase, is incorporated into some
commercially-available sunscreens, and is damaging to
cultured human skin cells [36]. Coating or doping TiO2
nanoparticles prior to their incorporation into sunscreen
is a method by which their photocatalytic activity can be
substantially reduced. Nevertheless, it may be reassuring
to note that the TiO2 nanoparticles in the sunscreen
used here, which had photocatalytic properties similar to
Degussa P25 ([37]; personal communication, [38]), did
not produce adverse effects in the long-term when
tested under the conditions of our study. Importantly,
however, we did not irradiate unprotected skin following
removal of the sunscreen. Future work might expose
skin with residual TiO2 particles left in skin furrows and
in hair follicles after washing. Once exposed to UVR ra-
ther than covered by recommended amounts of sunscreen
formulation [39], the biological impact of photocatalytic
particles in skin could be better ascertained.
No pathologies, apart from UVR-induced skin neo-
plasms in mice receiving UVR treatments but no
sunscreen, were found to be due to a common cause.
However, the relatively high incidence of adverse events in
the ZnO+UVR group in Series 1, which resulted in five
of the 10 mice in this treatment group failing to reach the
experimental endpoint, required careful consideration.
Mice in this group that did reach the experimental end-
point did not show treatment-related organ pathologies,
or altered gene expression profiles. Testing for microbial
infection was negative. The adverse events for three of the
five mice that did not reach the experimental endpoint
(two euthanized at week 20, and one at 32) were not
histologically ascribed to a common cause, whilst the
other two were found dead in their cage partially canniba-
lised (at weeks 10 and 13), and therefore no necroscopy
was performed and a cause of death was not determined.
While Zn excretion was not monitored throughout the
experiment, it appears unlikely that the mice in the
ZnO + UVR group were experiencing side effects linked
to excess Zn given no long-term tissue accumulation was
detected. Consistent with this, previous work has shown
that mechanisms in rodents [28] and humans [40] are suf-
ficient to maintain homeostasis, even under conditions of
excess Zn. Furthermore, when we repeated the long-term
exposure to ZnO sunscreen in Series 2, the high rate of
adverse events in ZnO +UVR was not reproduced, and
significant pathologies were not detected in the repeat
group post mortem. We therefore conclude that the
adverse events for ZnO+UVR in Series 1 were either
unrelated to each other, were related to UVR-mediated
immune suppression in the slightly higher UVR used in
the Series 1 protocol, and/or were due to an as-yet
unidentified factor in the cage.
Conclusions
In conclusion, this study addressed a perceived know-
ledge gap regarding the safety of long-term use of
sunscreens containing metal oxide nanoparticles. Sun-
screens containing ZnO or TiO2 nanoparticles, organic
UVR filters, or a mixture of both were applied topically
once per week over 36 weeks to immune-competent
hairless mice, a subset of whom were subsequently ex-
posed to UVR (Series 1). The experiment with minor
changes was repeated for the ZnO sunscreen (Series 2).
Mice across both Series were assessed for histopatho-
logical changes compared to untreated mice, as well as
for alterations in the concentrations of major organ tis-
sue Zn (ZnO sunscreen-treated mice, Series 1), and liver
tissue Ti (TiO2 sunscreen-treated mice, Series 1), and
whole genome transcriptional profiling (all mice, Series 1).
The major finding was that use of any of the sunscreens
protected mice from developing a range of adverse UVR-
mediated malignant and non-malignant skin neoplasms.
Use of the ZnO sunscreen was not associated with statisti-
cally significant variations in serum and internal organ
tissue Zn, whereas mice receiving applications of the TiO2
sunscreen showed a very small increase in liver Ti,
possibly due to chronic low-level ingestion of residual
TiO2 after washing. Neither of these sunscreens was
associated with substantial alteration at the level of gene
transcripts. In contrast, the transcriptional profile was
substantially disrupted in mice receiving treatments of the
organic sunscreen, which is of interest in light of work
elsewhere linking 4-MBC with endocrine disruption in ro-
dents (but not in humans). Overall, the results arising
from the current study showed that long-term use of sun-
screens containing ZnO or TiO2 nanoparticles provided
protection against UVR-induced skin neoplasms and did
not result in adverse biological outcomes in a hairless
mouse model.
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Methods
Series 1
Sunscreens used in this study
The three types of sunscreen (Table 5) used in this
study, each with an SPF of 30+, were purchased from a
local retail store in Sydney, Australia. One sunscreen
(ZnO) contained only ZnO (200 mg/g) as its active
ingredient. A second sunscreen (TiO2) contained a
mixture of TiO2 (40 mg/mL) and organic chemicals
(OCM, 70 mg/mL; B-MDM, 40 mg/mL) as UV-active
ingredients. This particular sunscreen was selected on the
basis of its similarity to a sunscreen that had elsewhere
been shown to contain nanoparticles with photocatalytic
properties similar to Degussa P25, a commercially-
available product comprising both the anatase and rutile
crystal phases of TiO2 nanoparticles ([37]; personal com-
munication). The third sunscreen (organic) contained only
organic chemicals as active ingredients (OCM, 99 mg/mL;
B-MDM, 19.8 mg/mL; 4- 4-MBC, 39.6 mg/mL; octocry-
lene, 9.9 mg/mL), and was prepared by the same manufac-
turer as the TiO2 sunscreen. The TiO2 and organic
sunscreens both contained OCM and B-MDM, albeit at
different concentrations, whereas 4-MBC and octocrylene
were present in the organic sunscreen only.
Nanoparticle characterisation
The presence of nanoparticles in the ZnO and TiO2
sunscreens was confirmed by extracting, imaging, and
size-measuring the particles. Particles were extracted
using a previously described method [37]: washing a
2-3 mg sample from each sunscreen sequentially twice
through hexane (30 mL), twice through ethanol (30 mL),
twice through water (30 mL), and once through acetone
(30 mL) for approximately one minute each wash. The
samples were centrifuged after each wash (room temp,
2 min, 7000 rpm), and supernatants were removed. It is
possible that this extraction procedure may have altered
either the particle size, agglomeration state, and/or surface
characteristics compared to in situ sunscreen. Following
the final acetone wash, the samples were air-dried, and the
particles were analysed for their size and shape by trans-
mission electron microscopy (TEM), using a Tecnai 12
TEM (FEI, Eindhoven, Netherlands) operating at 120 kV
with a variety of magnifications. For imaging, the powders
were dispersed in ethanol to form milky suspensions, and
4 μL aliquots were applied to 400-mesh carbon-coated
grids freshly glow-discharged for 15 s in nitrogen. The
samples were allowed to settle for approximately 1 min
with excess blotted using filter paper. Images were re-
corded using a MegaView III CCD camera (Olympus) and
sizes of nanoparticles determined using Image J software
(NIH) calibrated via the embedded scale bar.
Animal housing conditions
Female, albino, immune-competent, hairless SKH:QS
mice were supplied in-house by the CSIRO Animal
House from an in-bred colony that had been developed
from a seed cohort originally supplied by Sydney Univer-
sity, Australia [28]. Animals entered the study at 8 wks
of age. Animal experiments were approved by the
CSIRO North Ryde Animal Ethics Committee. For the
duration of the treatment period, mice were housed in
groups of 10 in open-topped polycarbonate cages in an
isolated temperature- (~21 °C) and moisture- (55-65 %
relative humidity) controlled room with a 14 h light/
10 h dark cycle, and had ad libitum access to water and
Gordon’s rat and mouse pellets (Gordon’s Speciality
Stock Feeds, Australia).
Source of UVR
Mice were irradiated beneath a purpose-built scanning
multi-lamp array, designed and constructed by the
University of Sydney and the CSIRO Division of Applied
Physics to simulate the solar spectrum. The irradiating
source, held 30 cm above the irradiance table surface,
comprised 8 X 140 W UVA lamps, 6 X 15 W UVB
lamps, 25 X 250 W tungsten halogen lamps, and 8 X
140 W 5’actinic blue-light lamps. UVC wavelengths were
excluded from the spectrum by filtering the emitted light
through cellulose acetate film, and the absence of UVC
wavelengths was confirmed spectroradiometrically. The
UVB lamps were held within a scanning apparatus with
a total scanning area of 140 cm x 50 cm, and scanning
frequency between 3-12 scans over the scanning area
per minute. All lamps were supplied by Commercial and
Domestic Lamp Supplies, NSW Australia. Irradiance
was measured and characterised by a portable, calibrated
(NIST Calibration # 08042932) StellarNet UV-VIS-NIR
spectroradiometer (EPP2000C UV-VIS CXR, Warsash
Scientific, NSW Australia). Lamps were switched on
15 min prior to use to allow UV output to stabilise.
Room temperature was stabilised by air-conditioning.
Table 5 Active ingredients of sunscreens used in this study
Sunscreen Active ingredients
ZnO ZnO (200 mg/g)
TiO2 TiO2 (40 mg/mL)
OCM (70 mg/mL)
B-MDM (40 mg/mL)
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Treatment regime
For Series 1, eighty mice were divided into eight treat-
ment groups of 10, and each mouse was treated once
per wk. In comparison to Australian standards, this
represents an infrequent application of sunscreen. Con-
versely, weekly exposure to sunscreen may exceed the
application frequency in far northern hemisphere coun-
tries. Mice in Control-UVR and Control + UVR received
no sunscreen; ZnO-UVR and ZnO + UVR received top-
ical applications of the ZnO sunscreen; TiO2-UVR and
TiO2 + UVR received topical applications of the TiO2
sunscreen; and Organic-UVR and Organic + UVR received
topical applications of the organic sunscreen. Control-
UVR, ZnO-UVR, TiO2-UVR and Organic-UVR received
no UVR treatment, and Control + UVR, ZnO+UVR,
TiO2 +UVR and Organic + UVR received approximately
29 kJ/m2 UVR (comprising an average of 27 kJ/m2 UVA
and 2 kJ/m2 UVB) per treatment. This dose was selected
on the basis of pilot data that had shown this dose to be
sufficient to elicit a statistically-significant thickening of the
dorsal skin area 48-72 h post-irradiation in the absence of
any sun-protection factor (data not shown). All mice re-
ceived a total of 30 treatments over the course of 36 wks.
The last treatment was on week 36 followed by necroscopy
approximately 24 h after the last irradiation.
Prior to each sunscreen application, and for the dur-
ation of each weekly treatment, mice in all groups were
fitted with Elizabethan collars (Braintree Scientific, USA)
to prevent self-grooming and consequent large-scale in-
gestion of the sunscreen formulations. A preliminary be-
havioural study conducted at the request of the CSIRO
North Ryde Animal Ethics Committee showed that mice
were not unduly bothered by the collars. Bedding was
removed from cages and replaced with a lining of paper
towel to minimise sunscreen removal by rubbing. Using
a gloved fingertip, sunscreen was applied at 2 mg/cm2
[39] to the head, ears, back, sides and tail of each mouse,
and sunscreens were left to equilibrate for 20 min before
UVR exposure, according to manufacturers’ instructions.
Although only dorsal skin thickness was measured, sun-
screen was applied to all skin areas exposed to UVR to
prevent localised sunburn. The total volume of sun-
screen applied varied slightly per mouse according to its
size, but on average approximated 110 μL.
For UVR treatments, mice in the same treatment
group were placed unrestrained in an open-topped cage
placed within a larger bed of ice that kept the cage cool
under the irradiating lamps. To avoid differences caused
by “hot” and “cold” irradiation spots within the total ir-
radiation area of 140 cm x 50 cm, cages were placed in
the same location on the irradiation table one at a time.
Time under lamps to deliver the standard UVR dose var-
ied slightly with each treatment and was calculated just
prior to each individual irradiation using SpectraWiz®
software packaged with the spectrometer. Thus, we
attempted to standardise the UVR dose received by dif-
ferent treatment groups. Following irradiation, mice
were returned to their cages lined with fresh paper towel
for 2 h, after which collars were removed and sunscreens
were washed from the mice using luke-warm pH bal-
anced soapy water, and soft cotton pads. Mice were then
dried using fresh cotton pads, and returned to cages
with clean standard bedding until their next weekly
treatment. Mice receiving no applications of sunscreen
were sham treated in that they had Elizabethan collars
applied, were held in cages lined with fresh paper towel
for 2 h, after which they were washed. Mice were not
observed to groom each other or themselves during
treatment periods. Once per month, the thickness of the
dorsal skin on each mouse was measured 72 h after the
last irradiation using electronic callipers (Mitutoyo
Absolute Digimatic CD-6”C).
After 36 wks (30 treatments), under anaesthesia in-
duced using an intraperitoneal injection of Xylazine
[(50 mg/kg)/ketamine (50 mg/kg)], mice were weighed
and then euthanized by cervical dislocation, and skin
neoplasms were counted and classified macroscopically.
The dorsal skin was carefully dissected, mounted on
cardboard, noting the head-tail orientation, and stored on
ice in 1 X Histochoice tissue fixative (Astral Scientific,
Australia) for histopathology. Major internal organs (brain,
liver, spleen, kidneys, lung and heart) were retrieved,
weighed and sectioned. Sections were either stored in 4 %
neutral buffered formalin at room temperature for histo-
pathology, or snap frozen in liquid nitrogen and
stored at -80 °C for other analyses.
Histopathology
Skin samples were processed within 24 h of dissection,
and sectioned by a commercial provider (VPS, University
of Sydney, Australia). All other organs were processed,
sectioned and stained by a commercial provider (Gribbles
Veterinary Pathology, Australia). Histopathological ana-
lysis of all samples was performed by the same veterinary
pathologist on a commercial basis (Gribbles Veterinary
Pathology, Australia). The histopathologist was not privy
to the nature of each treatment with the exception of
Control-UVR, which was identified as the untreated
control group to enable statistical comparisons. Abnor-
malities identified in organs were classified, typically on
their degree of severity, and the incidence within a
treatment group was then compared to the incidence
across all groups.
Measurement of tissue Zn by ICP-MS
Total Zn concentrations were measured by ICP-MS in
skin, brain, liver, spleen, kidney and lung tissues har-
vested from Control-UVR, Control + UVR, ZnO-UVR
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and ZnO +UVR. Frozen samples (0.04 g wet mass) were
processed and analysed by a commercial provider
(Advanced Analytical Australia). Five samples were mea-
sured for each treatment group except for Control + UVR
skin, for which four representative samples were
measured.
Measurement of liver Ti by ICP-MS
Total Ti concentrations in livers harvested from mice in
Control-UVR, TiO2-UVR and TiO2 +UVR were deter-
mined in-house by ICP-MS. Liver tissue (0.01 - 0.05 g wet
mass) was weighed into 50 ml PFA beakers with 10 ml
double-distilled concentrated nitric acid (Savillex DST-100)
and 0.5 ml hydrogen peroxide (≥30 %, TraceSELECT Ultra,
Fluka). The samples were open-vessel digested for 1 h at
70 °C, and further closed-vessel digested (lids added) at
70 °C for 2 h. Vessel lids were removed and solutions evap-
orated to dryness at 70 °C. The samples were further
digested in 5 ml of double-distilled concentrated nitric acid
and 0.5 ml hydrofluoric acid (48 %) at 70 °C for 2 h.
Following digestion, samples were evaporated to dryness,
resuspended in 2 % nitric acid, and stored in PFA vessels
until analysis. Total Ti concentrations in solutions were de-
termined using ICP-MS (Agilent 7700) by monitoring
mass/charge (m z-1) 49. Collision cell mode was used for
ICP-MS analysis using helium as a collision gas at a flow
rate of 4 ml min-1. The ICP-MS instrument was optimised
daily to minimise double charged and oxide interferences
to < 2 % (m z-1 70/ m z-1 140) and < 1 % (m z-1 156/ m z-1
140), respectively. Four to six representative samples were
measured for each treatment group. Selected samples were
spiked with 10 μg/L solution of Ti to examine the accuracy
of the digestion and analysis procedures. Mean spike re-
coveries were in good agreement with the tissue spiked Ti
concentrations (95 ± 2.7 %, n = 6).
Statistical analyses of data
All statistical analyses of data were performed using
GraphPad Prism 6.00 (GraphPad Software, USA), unless
otherwise specified. Histological findings in treatment
groups were assessed for statistical significance compared
to Control-UVR using a two-sided Fisher’s exact test
(alpha < 0.05). Differences between groups for skin thick-
ness and/or organ concentrations of Zn and Ti were
assessed for statistical significance by one-way ANOVA
with Tukey’s Multiple Comparisons Test (if three or more
groups), or unpaired t-tests with Welch’s Correction
(if only two groups), with significance set at p < 0.05.
Analysis of 28,853 gene transcripts in mouse liver by
whole-genome expression profiling
Liver tissue was chosen for an analysis of altered gene
expression in treated mice relative to controls on the
basis of previous work indicating a high exchange in the
liver of Zn from topically applied sunscreen with endogen-
ous Zn, as well as the development of an inflammatory
response from short-term exposure to a sunscreen formu-
lation without nanoparticles [28].
Procedures for RNA isolation from mouse liver samples
(30 mg wet weight) and measurements of concentration
and quality assurance were performed as described
elsewhere [28] using a NucleoSpin® RNA II kit (Macherey-
Nagel, Scientifix), a NanoDrop DN-1000 spectrophotom-
eter (Biolab), and an Agilent 2100 Bioanalyzer (RNA 6000
Nanochip™, Agilent Technologies), respectively. Samples
were prepared for microarray analysis using the Affyme-
trix GeneChip Mouse Gene 1.0 ST Array Combo kit and
Hybridisation, Wash and Stain Kit (Millennium Science)
following manufacturer’s instructions. Microchips were
hybridised (17 h, 45 °C, 60 rpm in an Affymetrix 640
GeneChip® Hybridization Oven), then washed using an
Affymetrix GeneChip® Fluidics Station 450, and scanned
using an Affymetrix 7G GeneChip® Scanner. All micro-
chips passed the associated quality-control procedures
recommended by Affymetrix. Representative samples
from six different mice in each treatment group were
prepared.
The microchips were processed in six batches of eight
chips by the same operator, following the same proced-
ure, with each batch processed on a different day. Each
batch contained one microchip from each of the eight
groups to minimize the consequences of batch effects
on downstream analysis [41]. Transcripts were calcu-
lated as being up- or down-regulated compared to un-
treated mice as described elsewhere [41] using Matlab
Bioinformatics and Statistical toolboxes, and normalized
using robust multi-array average. Batch effects were re-
moved, and control for false discovery was set at 10 % using
in-house tools [42]. Transcripts identified as being differen-
tially expressed with statistical significance compared to
Control-UVR were analyzed using Ingenuity Pathways
Analysis (IPA) (Ingenuity® System, www.ingenuity.com),
taking into account whether they were under-expressed or
over-expressed.
Series 2
To further investigate adverse events resulting in the un-
scheduled deaths of five of 10 mice in the ZnO +UVR
group of Series 1, the experiment was repeated as
described above for the control and ZnO ±UVR treat-
ment groups with minor modifications. To distinguish a
potential treatment effect from an unidentified cage-
associated factor, the 10 mice in each treatment group
were housed in two cages each of five mice rather than
one cage of 10 as in Series 1. The weekly UVR dose of
29 kJ/m2 applied in Series 1 had been selected on the
basis that it elicited a statistically significant level of skin
thickening in pilot experiments; however exposure to
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UVR has been associated in mice and humans with im-
mune suppression [43], and therefore the total UVR
dose was lowered slightly in Series 2 to 27 kJ/m2, to
bring it closer to doses used elsewhere [17, 18, 44, 45].
Furthermore, whilst bearing in mind that extended ex-
posure to the UVA component of UVR is hardly benign
[19, 20], UVB can efficiently induce direct damage to
cellular components including DNA and proteins [3],
and increasing UVA levels relative to UVB has been as-
sociated with a decrease in UVB-mediated cell apoptosis
[21]. Therefore, the UVB dose used in Series 2 was low-
ered from 2 (used in Series 1) to 1.4 kJ/m2 and the UVA
dose was adjusted from 27 to 25.6 kJ/m2, resulting in a
UVA:UVB ratio greater than 17 as found under me-
teorological conditions [20], and more closely reflecting
the relative percentages UVA and UVB in total UVR on
a summer’s day at noon in Northern European latitudes
[22]. It is important to emphasize, however, that both
Series 1 and 2 were not designed to be UVR carcinogen-
esis experiments, but rather experiments to test the
long-term biological impact of using sunscreens, with
UVR as a variable. Mice in Series 2 received 32 treat-
ments over 36 wks, using the same ZnO sunscreen as
for Series 1. The last treatment was on week 36 followed
by necropsy approximately 24 h after the last irradiation.
Post-mortem, histological analyses were performed by
the same veterinary histopathologist as in Series 1. Tis-
sue Zn concentrations were not measured in Series 2,
and global gene-expression profiling in liver was not
performed.
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